Goldman Sachs Group set a €21.00 ($24.42) target price on Evonik Industries (FRA:EVK) in a report issued on Tuesday morning, Borsen Zeitung reports. The brokerage currently has a sell rating on the stock.

A number of other equities analysts also recently commented on the stock. Berenberg Bank set a €29.00 ($33.72) price objective on shares of Evonik Industries and gave the stock a buy rating in a research note on Tuesday, August 6th. Morgan Stanley set a €34.00 ($39.53) price objective on shares of Evonik Industries and gave the stock a buy rating in a research note on Monday, July 15th. Sanford C. Bernstein set a €31.00 ($36.05) price objective on shares of Evonik Industries and gave the stock a buy rating in a research note on Thursday, August 1st. Kepler Capital Markets set a €25.00 ($29.07) price objective on shares of Evonik Industries and gave the stock a sell rating in a research note on Tuesday, May 7th. Finally, Independent Research set a €25.00 ($29.07) price objective on shares of Evonik Industries and gave the stock a neutral rating in a research note on Wednesday, August 7th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and ten have given a buy rating to the stock. The stock presently has an average rating of Hold and an average price target of €30.05 ($34.94).

Shares of FRA:EVK opened at €21.23 ($24.69) on Tuesday. Evonik Industries has a 52 week low of €26.78 ($31.14) and a 52 week high of €32.97 ($38.34). The firm has a 50 day moving average of €24.87 and a 200 day moving average of €25.14.

Evonik Industries Company Profile

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Read More: What are the most popular ETFs

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.